{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Multi-phase, Dose-Escalation followed by an Open-label, Randomized, Crossover Study of Oral ASTX030 (Cedazuridine and Azacitidine Given in Combination) Versus Subcutaneous Azacitidine in Subjects with Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-multi-phase-dose-escalation-followed-by-an-open-label-randomized-crossover-study-of-oral-astx030-cedazuridine-and-azacitidine-given-in-combination-versus-subcutaneous-azacitidine-in-subjects-wi\/#breadcrumbitem"}]}